arrow
R

Rhonda E. Ries

Fred Hutchinson Cancer Center
H指数:36
被引数:9,155

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity

RAS突变在急性髓系白血病中的临床意义:预后意义取决于涉及的基因和突变复杂性

2026-05-140
OAAI
Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

联合抑制Menin和MEK以靶向预后不良的KMT2A重排RAS通路突变急性髓系白血病

2026-05-070
OAAI
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia

DLK1是GATA1s驱动的依赖性和唐氏综合征相关髓系白血病的治疗靶点

2026-04-090
OAAI
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease

分子风险标志物定义唐氏综合征髓系白血病的复发风险,超越可测残留病灶

2025-10-240
OAAI
Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia

急性髓系白血病的表观基因组学诊断与预后

2025-07-290
OAAI
Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

快速长读长表观基因组学对急性髓系白血病的诊断与预后

BLOOD
IF23.1
2024-11-050
PRE
Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG

NPM1突变急性髓系白血病中ELN2022风险分层的评估:一项来自Fred Hutch和SWOG的研究

BLOOD
IF23.1
2024-11-050
PRE
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target (vol 132, e157101, 2022)
2024-08-150
OAAI
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
Nature
IF48.5
2024-08-140
PRE
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis

AML中IDH突变的特征和预后影响: COG,SWOG和ECOG分析

2023-10-0218
OAAI
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia
2023-02-2330
OAAI